View printer-friendly version << Back Aerpio Therapeutics Completes Enrollment of Phase 2 Study of Tie2 Activator AKB-9778 for the Treatment of Patients with Diabetic Macular Edema Completes-Enrollment-Phase-2-Study-AKB-9778.pdf 389.9 KB
View printer-friendly version << Back Aerpio Therapeutics Completes Enrollment of Phase 2 Study of Tie2 Activator AKB-9778 for the Treatment of Patients with Diabetic Macular Edema Completes-Enrollment-Phase-2-Study-AKB-9778.pdf 389.9 KB